On Friday, Altimmune Inc (NASDAQ: ALT) was -0.33% drop from the session before settling in for the closing price of $9.14. A 52-week range for ALT has been $4.71 – $14.84.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
It was noted that within the last five years, the titan of the Healthcare sector saw sales topped by 115.21%. When this article was written, the company’s average yearly earnings per share was at 18.24%. With a float of $70.53 million, this company’s outstanding shares have now reached $71.12 million.
The extent of productivity of a business whose workforce counts for 59 workers is very important to gauge. In terms of profitability, gross margin is -3857.69%, operating margin of -191365.38%, and the pretax margin is -199076.92%.
Altimmune Inc (ALT) Insider and Institutional Ownership
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Altimmune Inc stocks. The insider ownership of Altimmune Inc is 0.83%, while institutional ownership is 56.20%. The most recent insider transaction that took place on Aug 19 ’24, was worth 110,547. In this transaction Director of this company sold 16,011 shares at a rate of $6.90, taking the stock ownership to the 41,958 shares.
Altimmune Inc (ALT) Latest Financial update
According to the Wall Street analysts, stocks earnings will be around 18.24% per share during the next fiscal year.
Altimmune Inc (NASDAQ: ALT) Trading Performance Indicators
You can see what Altimmune Inc (ALT) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 16.87. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 12916.46.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.55, a number that is poised to hit -0.34 in the next quarter and is forecasted to reach -1.26 in one year’s time.
Technical Analysis of Altimmune Inc (ALT)
The latest stats from [Altimmune Inc, ALT] show that its last 5-days average volume of 5.02 million was superior to 3.86 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 44.29%. Additionally, its Average True Range was 0.84.
During the past 100 days, Altimmune Inc’s (ALT) raw stochastic average was set at 65.17%, which indicates a significant increase from 55.02% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 77.38% in the past 14 days, which was lower than the 85.20% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $7.39, while its 200-day Moving Average is $7.57. Now, the first resistance to watch is $9.66. This is followed by the second major resistance level at $10.21. The third major resistance level sits at $10.53. If the price goes on to break the first support level at $8.80, it is likely to go to the next support level at $8.48. The third support level lies at $7.93 if the price breaches the second support level.
Altimmune Inc (NASDAQ: ALT) Key Stats
There are 71,125K outstanding shares of the company, which has a market capitalization of 645.82 million. As of now, sales total 430 K while income totals -88,450 K. Its latest quarter income was 10 K while its last quarter net income were -22,850 K.
